Botulinum Toxin A Delivery Via MMP Technique: An Emerging Therapeutic Approach for Frontal Fibrosing Alopecia

    Simone Ramos Nogueira Guerra Neri, Marta de Oliveira Domingos, Nílceo Schwery Michalany, Alexandre Ozores Michalany, Célia Luíza Petersen Vitello Kalil
    Image of study
    TLDR Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.
    The document presents a case study of a patient with early-stage Frontal Fibrosing Alopecia (FFA), a disease with unknown causes and no cure. The patient underwent three monthly sessions of treatment with 30 units of Botulinum Toxin Type A, delivered via the MMP® (Microinfusion of drugs through the skin) technique. The treatment resulted in a significant improvement in the patient's condition, inhibiting the inflammatory process and noticeably increasing follicular density in the treated area. This suggests that Botulinum Toxin Type A delivered via MMP® could be a promising therapeutic approach for FFA.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 15 results